biOasis Technologies Ord Shs V.BTI.H

RE:RE:RE:RE:RE:RE:August

[prophetoffactz]

"Make the argument, beenthere, that xB3 doesn't support a strong negotiating position."

A strong negotiating position generally doesn't mean that your stock has collapsed to a $.12 bid and that you are out of money in 19 business days and have to do something fast for cash. Let's hope the more than two parties that were said to be interested in the cancer assets, etc., represent a more vigorous market. The market for BTI's stock doesn't appear to be providing a strong financing option at this time. 

"Based on its current cash burn rate, the Company anticipates that its existing cash balance is sufficient to fund operation through approximately August 2022. The Company will need to raise additional working capital through the sale of common shares, the issuance of debt or by entering into license or collaboration agreements to fund its operations and preclinical studies. The Company is actively pursuing financing sources in order to continue funding operations. As disclosed in the financial statements, these factors indicate the existence of a material uncertainty that may raise significant doubt about the Company’s ability to continue as a going concern."